Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma
Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer
War in Ukraine: Global cancer aid to support refugees
War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis
Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer
RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies
Adagrasib shows CNS penetration and encouraging intracranial activity for KRASG12C-mutated NSCLC and active, untreated CNS metastases
Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy
Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
Momelotinib superior to danazol in symptomatic and anaemic myelofibrosis patients previously treated with a JAK inhibitor
Biomarker analysis of the NeoALTTO trial provides oncofertility insight for younger breast cancer patients
ASCO 2022: Latest in prostate cancer, including PARP inhibitors